Devdatt Kurdikar
Chairman, President and Chief Executive Officer, Embecta Corp.
Director since 2024
Chairman, President and Chief Executive Officer of Embecta Corp. (embecta) since February 2026, and President, Chief Executive Officer and director of embecta since its spinoff from Becton, Dickinson and Company (BD) on April 1, 2022. He was the Worldwide President of Diabetes Care at BD from 2021 until the embecta spinoff. Mr. Kurdikar was President and CEO of Cardiac Science Corporation from 2016 to 2019. He also served with Boston Scientific Corporation, American Medical Systems and Baxter International, Inc. and The Monsanto Company. Mr. Kurdikar holds a Bachelor in Chemical Engineering from the University of Bombay (India), a Master of Science in Chemical Engineering from Washington State University, a Ph.D. in Chemical Engineering from Purdue University and a Master of Business Administration from Washington University.
Other Public Board Memberships
Other Relevant Experience
Member of the Compensation and Management Development Committee
Chair of the Corporate Governance Committee